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Introduction
Outdoor air pollution is a complex mixture 
containing a number of known carcinogens 
and has been associated with increased lung 
cancer risk in many studies over the past 
50 years. Past reviews of the body of evidence 
regarding outdoor and household air pollution 
indicated that both were associated with lung 
cancer risk; specifically, exposures to increased 
levels of particles, as well as other indices of air 
pollution, were associated with increased lung 
cancer risk. However, the evidence was consid-
ered inconclusive regarding which specific 
components of the air pollution mixture are 
driving the increased risk (Samet and Cohen 
2006). The International Agency for Research 
on Cancer (IARC) recently concluded that 
exposure to outdoor air pollution and to 
particulate matter (PM) in outdoor air is 
carcinogenic to humans (IARC Group 1) and 
causes lung cancer (IARC, in press; Loomis 
et al. 2013). Epidemiological studies of 
long-term residential exposure to outdoor air 
pollution in terms of PM played a critical role 
in IARC’s evaluation.
In this manuscript, which originated 
with the IARC review, we provide meta-
analyses of the lung cancer risk associated 
with exposure to PM in outdoor air, specifi-
cally PM2.5 (particles with aerodynamic 
diameter ≤ 2.5 μm, or fine particles) and 
PM10 (≤ 10 μm, or inhalable particles). We 
performed analyses in subgroups defined by 
geographic region, potential confounders and 
effect modifiers, and exposure assessment 
method. We also examined the influence of 
single studies to the overall meta-estimate.
Methods
Literature search. The studies included in this 
analysis were a key component of the epide-
miological evidence reviewed by the IARC 
Working Group in its evaluation of the 
carcinogenicity of PM, as reported in IARC 
Monograph 109 (IARC, in press; Loomis 
et al. 2013). Relevant studies were identified 
in several stages, beginning with a systematic 
search of PubMed (http://www.ncbi.nlm.nih.
gov/pubmed/) using the keywords “air pollu-
tion OR particulate matter OR traffic AND 
cancer” in the title or abstract, with the results 
restricted to studies of humans. An initial 
search was conducted in December 2012 and 
updated automatically through October 2013. 
This search retrieved 604 studies.
Abstracts of the papers retrieved in the 
electronic search were screened manually for 
relevance to the topic of the IARC Monograph 
on outdoor air pollution. Ecological studies, 
with data on both outcome and exposure 
collected at the aggregate level, were excluded 
because of the inherent limitations of such 
studies. Instead, we considered all cohort 
and case–control studies available that 
provided individual outcome information 
and—in many cases—individual measures 
of exposure. The reference lists of the papers 
judged to be relevant at this stage were then 
searched for other potentially relevant papers, 
which were screened in turn. Members of the 
working group who were familiar with the 
research identified three additional studies 
that were in press at the time of the electronic 
search. Through this process, 201 potentially 
relevant papers were identified. Electronic 
full-text copies of those papers were made 
available to members of the working group, 
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Background: Particulate matter (PM) in outdoor air pollution was recently designated a Group I 
carcinogen by the International Agency for Research on Cancer (IARC). This determination was 
based on the evidence regarding the relationship of PM2.5 and PM10 to lung cancer risk; however, 
the IARC evaluation did not include a quantitative summary of the evidence.
oBjective: Our goal was to provide a systematic review and quantitative summary of the evidence 
regarding the relationship between PM and lung cancer.
Methods: We conducted meta-analyses of studies examining the relationship of exposure to PM2.5 
and PM10 with lung cancer incidence and mortality. In total, 18 studies met our inclusion criteria 
and provided the information necessary to estimate the change in lung cancer risk per 10-μg/m3 
increase in exposure to PM. We used random-effects analyses to allow between-study variability to 
contribute to meta-estimates.
results: The meta-relative risk for lung cancer associated with PM2.5 was 1.09 (95% CI: 
1.04, 1.14). The meta-relative risk of lung cancer associated with PM10 was similar, but less precise: 
1.08 (95% CI: 1.00, 1.17). Estimates were robust to restriction to studies that considered potential 
confounders, as well as subanalyses by exposure assessment method. Analyses by smoking status 
showed that lung cancer risk associated with PM2.5 was greatest for former smokers [1.44 (95% CI: 
1.04, 1.22)], followed by never-smokers [1.18 (95% CI: 1.00, 1.39)], and then current smokers 
[1.06 (95% CI: 0.97, 1.15)]. In addition, meta-estimates for adenocarcinoma associated with PM2.5 
and PM10 were 1.40 (95% CI: 1.07, 1.83) and 1.29 (95% CI: 1.02, 1.63), respectively.
conclusion: The results of these analyses, and the decision of the IARC Working Group to 
classify PM and outdoor air pollution as carcinogenic (Group 1), further justify efforts to reduce 
exposures to air pollutants that can arise from many sources.
citation: Hamra GB, Guha N, Cohen A, Laden F, Raaschou-Nielsen O, Samet JM, 
Vineis P, Forastiere F, Saldiva P, Yorifuji T, Loomis D. 2014. Outdoor particulate matter 
exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect 
122:906–911; http://dx.doi.org/10.1289/ehp.1408092Air pollution and lung cancer risk
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who reviewed the search results and the 
papers in detail and selected those studies 
considered relevant for inclusion in the 
IARC Monograph.
Inclusion and exclusion criteria. Studies 
were included in the current meta-analysis 
if they provided quantitative estimates of 
residential exposure to PM2.5 and/or PM10. 
Further, studies were required to provide 
quantitative estimates of the change in lung 
cancer incidence or mortality associated 
with exposure to either indicator of PM; this 
could be reported as the change in risk per 
microgram per cubic meter or per quantile 
of exposure. Studies that reported results for 
the association of lung cancer with other air 
pollutants or exposure to traffic but did not 
provide quantitative estimates for PM were 
not included in the meta-analysis.
We considered lung cancer mortality and 
incidence studies together because mortality 
is a valid indicator of incidence. Survival rates 
provided by the Surveillance, Epidemiology, 
and End Results (SEER) program from 2003 
to 2009 estimate 5-year survival rates among 
U.S. white males and females at 14.5% and 
19.5%, respectively (Howlader et al. 2013). 
Because the case–fatality rate is high for lung 
cancer, mortality and incidence are compa-
rable; thus, it is reasonable to include both 
outcomes within the same meta-analysis.
Where multiple publications included 
overlapping study populations, we included 
the publication that considered the largest 
number of cases and/or that evaluated results 
based on the longest follow-up. In addition, 
we did not place any restrictions based on 
whether or not a study adjusted for specific 
confounders. All studies were adjusted for 
the effect of age and sex; however, the sets of 
other potential confounders for which adjust-
ments were made varied by study. Thus, the 
sensitivity of estimates to confounder adjust-
ment was considered. All risk estimates were 
abstracted by one of the authors, reviewed 
by the IARC Working Group, and double-
checked for accuracy by a second author.
Statistical analyses. All study estimates 
were converted to represent the change in 
lung cancer risk per 10-μg/m3 unit increase 
in exposure to PM2.5 or PM10. If we could 
not reliably convert the values in a partic-
ular study to the aforementioned units, we 
contacted the authors of the original study for 
further information. If information necessary 
to convert estimates could not be obtained, 
the study was excluded from consideration.
Estimates from the studies were combined 
using a random-effects model, which allowed 
between-study heterogeneity to contribute to 
the variance (DerSimonian and Laird 1986). 
I2 values are reported, representing the esti-
mated percent of the total variance that is 
Table 1. Summary of studies included in meta-analyses of lung cancer risk associated with exposure to particulate matter.
Continent
Study 
ID Reference No. of events
Total 
population Study period
Exposure assessment 
method
Exposure distribution 
(mean ± SD) Study
North America
California, USA 1 Beeson et al. 1998 16 (incidence) 6,338 1977–1992 Fixed site monitor PM10: 51.0 ± 16.5 AHSMOG
California, USA 2 McDonnell et al. 
2000
13 (mortality) 3,769 1977–1992 Fixed site monitor PM2.5: 31.9 ± 10.7 AHSMOG
United States 3 Pope et al. 2002 NA 415,000 1982–1998 Fixed site monitor PM10: 28.8 ± 5.9 ACS-CPS II
United States 4 Krewski et al. 2009 9,788 (mortality) 499,968 1982–2000 Fixed site monitor PM2.5: 21.2 ± 10.8  
(1979–1983)  
PM2.5: 14.0 ± 9.1 
(1999–2000)
ACS-CPS II
Los Angeles, CA, 
United States
5 Jerrett et al. 2013 1,481 (mortality) 73,711 1982–2000 Land use regression PM2.5: 14.1 ± 12.4 ACS-CPS II
United States 6 Hart et al. 2011 800 (mortality) 53,814 1985–2000 Inverse distance 
weighting (PM2.5)/
spatio temporal  (PM10)
PM2.5: 14.1 ± 4.0  
PM10: 26.8 ± 6.0
TrIPS
California, USA 7 Lipsett et al. 2011 275 (PM10),  
234 (PM2.5) (mortality)
101,784 (PM10), 
73,489 (PM2.5)
1997–2005 Inverse distance 
weighting
PM2.5: 15.6 ± 4.5  
PM10: 29.2 ± 9.8
CTS
United States 8 Lepeule et al. 2012 632 (mortality) 8,096 1975–2009 Fixed site monitor PM2.5: 15.9b Harvard Six Cities Study
Canada 9 Hystad et al. 2013 2,390 (incidence) 5,897 1994–1997 Spatio temporal  model PM2.5: 11.9 ± 3.0 National Enhanced Cancer 
Surveillance System Case-
Control study
United States 10 Puett et al. 2014 1,648 (incidence) 97,865 1998–2010 Spatio temporal  model PM2.5: 13.1 ± 3.0  
PM10: 21.6 ± 6.0
NHS
Europe
Netherlands 11 Beelen et al. 2008 1,940 (incidence) 120,852 1986–1997 Land use regression PM2.5: 28.3 ± 2.1 Netherlands Cohort study of 
Diet and Cancer.
United Kingdom 12 Carey et al. 2013 5,273 (mortality) 830,842 2003–2007 Air dispersion PM2.5: 12.9 ± 1.4  
PM10: 19.7 ± 2.3
Clinical Practice Research 
Datalink
Italy 13 Cesaroni et al. 2013 12,208 (mortality) 1,265,058 2001–2010 Air dispersion PM2.5: 23.0 ± 4.4 Rome Longitudinal Study
Germany 14 Heinreich et al. 2013 41 (mortality) 4,752 1980–2008 Fixed site monitor PM10: 43.7b German Women’s Health 
Study
European Union 15 Raaschou-Neilsen 
et al. 2013
2,095 (incidence) 312,944 1990s Land use regression PM2.5: 13.4 ± 1.2 
PM10: 21.3 ± 2.7
ESCAPE
Other
China 16 Cao et al. 2011 624 (mortality) 70,947 1991–2000 Fixed site monitor PM2.5:a China National Hypertension 
follow-up survey
Japan 17 Katanoda et al. 2011 421 (mortality) 63,520 1983–1995 Fixed site monitor PM2.5: 28.8b Three Prefecture Cohort 
Study
New Zealand 18 Hales et al. 2012 1,686 (mortality) 1,050,222 1996–1999 Land use regression PM10: 8.3 ± 8.4 New Zealand Census 
Mortality Study
Abbreviations: AHSMOG, Adventist Health Study on Smog; ACS-CPS II, American Cancer Society Cancer Prevention Study II; CTS, California Teachers Study; ESCAPE, European Study 
of Cohorts for Air Pollution Effects; NA, not available; NHS, Nurses’ Health Study; TrIPS, Trucking Industry Particle Study.
aMean and SD of PM2.5 for Cao et al. (2011) could not be obtained. The numbers reported represent the range of exposure estimated by converting TSP to PM2.5 with a 3:1 ratio. bSD not 
reported.Hamra et al.
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explained by between-study heterogeneity 
(Higgins et al. 2003). We also conducted chi-
square tests of homogeneity to compare meta-
estimates divided into subgroups by region, 
smoking status, and exposure assessment 
method. In some cases, individual studies 
reported results only for subgroups, such as 
by sex or time period of study. Such stratified 
estimates were first combined into a single, 
study-specific estimate using fixed-effects 
regression and then included in analyses to 
obtain the overall meta-estimate. In addition, 
studies restricted to certain subgroups were 
considered to have been adjusted for possible 
confounding by the subgroup of interest; 
for example, studies among men only 
were considered to have accounted for the 
confounding effects of sex. Finally, forest and 
funnel plots were created to provide a visual 
summary of the distribution of study-specific 
effect estimates. In lieu of statistical tests of 
funnel plot asymmetry, we conducted trim 
and fill analyses. The trim and fill analysis 
method removes the smallest studies until a 
symmetric funnel plot is obtained; then, those 
removed studies are added back with their 
hypothetical “counterparts” to recalculate the 
meta-estimate that would have been obtained 
from a symmetric funnel plot (Duval and 
Tweedie 2000; Higgins et al. 2008). Analyses 
were conducted using STATA (v12.1; 
StataCorp, College Station, TX, USA).
Results
Studies included. We identified 17 cohort 
studies (Beelen et al. 2008; Beeson et al. 
1998; Cao et al. 2011; Carey et al. 2013; 
Cesaroni et al. 2013; Hales et al. 2012; Hart 
et al. 2011; Heinrich et al. 2013; Jerrett et al. 
2013; Katanoda et al. 2011; Krewski et al. 
2009; Lepeule et al. 2012; Lipsett et al. 2011; 
McDonnell et al. 2000; Naess et al. 2007; 
Pope et al. 2002; Raaschou-Nielsen et al. 
2013) and one case–control study (Hystad 
et al. 2013) of lung cancer that provided 
estimates of the quantitative relationships 
between the risk of lung cancer and exposure 
to PM2.5 or PM10 that could be expressed per 
10-μg/m3 change in PM. Estimates from one 
cohort study (Naess et al. 2007) could not be 
converted to units of 10-μg/m3, and thus, this 
study did not contribute to the meta-estimates. 
In addition, a recently accepted paper (Puett 
et al. 2014) was included in this analysis 
because it met the criteria for inclusion.
Table 1 summarizes the 18 studies 
included in these analyses. In total, there were 
14 and 9 studies that provided estimates of 
the lung cancer risk associated with exposure 
to PM2.5 and to PM10, respectively. There 
were four studies from Europe, eight studies 
from North America, and two studies from 
other regions that contributed to the overall 
meta-estimates for PM2.5. Regarding PM10, 
there were three European studies, five 
North American studies, and one study from 
another region that contributed to the overall 
meta-estimates.
Jerrett et al. (2013) studied a subset of 
the full American Cancer Society Cancer 
Prevention Study II (ACS-CPS II) cohort 
considered by Krewski et al. (2009). However, 
Jerrett et al. (2013) used land use regression to 
estimate PM, whereas Krewski et al. (2009) 
used fixed site monitors; furthermore, each 
study considered different confounders in 
their final analyses. Therefore, we excluded 
Jerrett et al. (2013) from all analyses where it 
would overlap with Krewski et al. (2009).
Overall meta-estimates for PM2.5 and 
PM10. Figure 1 presents the estimated effect 
for each study, grouped by the continent where 
the study was conducted; Jerrett et al. (2013) 
is included in Figure 1 for visualization, but 
it does not contribute to overall or continent-
specific meta-estimates. All estimates represent 
the change in the risk of lung cancer mortality/
incidence associated with a 10-μg/m3 increase 
in PM2.5 or PM10. The meta-relative risk 
[95% confidence interval (CI)] for lung cancer 
associated with PM2.5 was 1.09 (95% CI: 
1.04, 1.14). The meta-relative risk of lung 
cancer associated with PM10 was similar, but 
less precise: 1.08 (95% CI: 1.00, 1.17). When 
restricting our analysis to cohort studies that 
examined both measures of PM [the Adventist 
Health Study on Smog (AHSMOG) study, 
ACS-CPS II, Trucking Industry Particle Study 
(TrIPS), California Teachers Study (CTS), 
Nurses’ Health Study (NHS), Clinical Practice 
Figure 1. Estimates of lung cancer risk associated a 10-μg/m3 change in exposure to PM2.5 (A) and PM10 (B) 
overall and by geographic region of study. Weights represent the contribution of each study effect estimate 
to the overall meta-estimate.
aJerrett et al. (2013) contributes neither to the overall nor to the continent-specific meta-estimates; it is only included here 
for visualization. 
1.39 (0.79, 2.46)  0.66
1.09 (1.05, 1.13)  21.19
1.18 (0.95, 1.48)  3.77
0.95 (0.70, 1.28)  2.22
1.37 (1.07, 1.75)  3.20
1.29 (0.95, 1.76)  2.14
1.12 (0.91, 1.37)  — 
1.06 (0.90, 1.24)  6.48
1.11 (1.05, 1.16)   39.67
1.16 (1.02, 1.32)  12.18
0.98 (0.95, 1.01)  17.84
1.08 (0.91, 1.30)  9.12
0.93 (0.81, 1.07)  11.44
1.04 (0.95, 1.14)  14.55
1.02 (0.96, 1.09)  65.12
0.81 (0.63, 1.04)  3.11
1.11 (0.86, 1.43)  3.07
1.05 (1.01, 1.10)  20.21
1.39 (0.91, 2.13)  1.17
1.03 (0.89, 1.20)  27.56
1.03 (0.88, 1.21)  10.16
2.39 (1.35, 4.22)  1.66
1.22 (1.03, 1.45)  9.60
1.27 (0.96, 1.68)  21.42
1.16 (1.04, 1.29)  13.45
1.08 (1.00, 1.17)  100.00
1.03 (1.00, 1.07)  21.25
1.24 (1.12, 1.37)  11.52
1.13 (0.94, 1.34)  32.77
1.09 (1.04, 1.14)  100.00 Overall (I 2 = 53.0%, p = 0.010)
North America
North America
Study by region
Study by region
RR (95% CI) Weight
RR (95% CI) Weight
Europe
Europe
Other
Other
0.5 12 3
0.5 12 5
McDonell et al. 2000 
Krewski et al. 2009 
Hart et al. 2011 
Lipsett et al. 2011 
Lepeule et al. 2012 
Hystad et al. 2013 
Jerrett et al. 2013a 
Puett et al. 2014 
Subtotal (I 2 = 0.0%, p = 0.490)
Beelen et al. 2008 
Carey et al. 2013 
Cesaroni et al. 2013 
Raaschou-Nielsen et al. 2013 
Subtotal (I 2 = 50.0%, p = 0.112)
Beeson et al. 1998 
Pope et al. 2002 
Hart et al. 2011 
Lipsett et al. 2011 
Puett et al. 2014 
Subtotal (I 2 = 57.7%, p = 0.051)
Carey et al. 2013 
Heinrich et al. 2013 
Raaschou-Nielsen et al. 2013 
Subtotal (I 2 = 76.5%, p = 0.014)
Hales et al. 2012 
Overall (I 2 = 74.6%, p = 0.000)
Cao et al. 2011 
Katanoda et al. 2011 
Subtotal (I 2 = 91.0%, p = 0.001)Air pollution and lung cancer risk
Environmental Health Perspectives  •  volume 122 | number 9 | September 2014  909
Research Datalink, and European Study of 
Cohorts for Air Pollution Effects (ESCAPE)], 
the meta-estimates associated with PM2.5 and 
PM10 are 1.09 (95% CI: 1.06, 1.13) and 1.07 
(95% CI: 0.98, 1.15), respectively. Random-
effects estimation for these values may 
suggest inconsistencies between studies. The 
between-study variance for PM2.5 and PM10 
were 56.4% and 74.6% of the total variance, 
respectively. Chi-square tests of homogeneity 
provided little evidence of difference between 
continent-specific meta-estimates for PM2.5 
(p = 0.656) and modest evidence of hetero-
geneity by continent-specific meta-estimates 
for PM10 (p = 0.074).
Funnel plots for both PM2.5 and PM10 
were visually asymmetrical (see Supplemental 
Material, Figure S1); thus, trim and fill 
analyses were conducted to test the volume 
of information that would be necessary to 
construct a symmetrical funnel plot. With 
respect to PM2.5, the estimate accounting for 
funnel plot asymmetry was 1.08 (95% CI: 
1.03, 1.13); this estimate required trimming 
and filling in the funnel plot with three 
hypothetical studies. With regard to PM10, 
the estimate accounting for funnel plot asym-
metry was 1.00 (95% CI: 0.92, 1.08); this 
estimate required filling in the funnel plot 
with four hypothetical studies. In addition, we 
conducted influence analyses to determine if 
any specific study highly influenced the overall 
meta-estimate. Results showed that, overall, 
meta-estimates were not reliant on inclu-
sion of any specific study; confidence inter-
vals for meta-estimates excluding one study 
at a time overlapped, and meta-  estimates 
consistently supported a positive associa-
tion between PM exposure and lung cancer 
incidence and mortality (see Supplemental 
Material, Table S1).
Subgroup analyses. Table 2 presents 
subgroup analyses by continent, exposure 
assessment method, and smoking status; in 
addition, meta-estimates excluding studies 
that did not adjust for confounders of interest 
are presented. Region-specific meta-  estimates 
are also summarized, with individual study 
estimates, in Figure 1. The PM2.5 meta-
estimates for Europe, North America, and 
other continents were 1.03 (95% CI: 
0.89, 1.20), 1.11 (95% CI: 1.05, 1.16), 
and 1.13 (95% CI: 0.94, 1.34), respectively 
(Figure 1A). Although these estimates show 
a slight variation, their confidence intervals 
are largely overlapping, and homogeneity 
tests suggest no evidence of differences across 
regions. Regarding PM10, the meta-estimates 
for Europe and North America are 1.27 
(95% CI: 0.96, 1.68) and 1.02 (95% CI: 
0.96, 1.09), respectively (Figure 1B). The 
estimate from North America, based on five 
studies, was more precise and less suggestive 
of a relationship between PM10 and lung 
cancer risk. A study in New Zealand (Hales 
et al. 2012) was the only one available outside 
of Europe and North America; the reported 
estimate from this study was 1.16 (95% CI: 
1.04, 1.29). Estimates by continent do not 
appear to be heterogeneous (Table 2).
With regard to exposure assessment 
method, meta-estimates from studies using 
fixed site monitors were compared to those 
from studies using modeling-based estimation 
techniques, for example, land use regression. 
For both PM2.5 and PM10 exposure, the 
meta-estimate from studies using fixed site 
monitors was higher than the meta-estimate 
from studies using modeling-based exposure 
assessment techniques. However, homo-
geneity tests for PM2.5 and PM10 (p = 0.268 
and p = 0.484, respectively) suggested no 
difference between exposure assessment 
method subgroups (Table 2).
We also conducted analyses by subgroups 
of current, former, and never-smokers. The 
meta-estimate for lung cancer risk associated 
with PM2.5 was greatest for former smokers, 
1.44 (95% CI: 1.04, 2.01) followed by never-
smokers, 1.18 (95% CI: 1.00, 1.39), and then 
current smokers, 1.06 (95% CI: 0.97, 1.15). 
A test of homogeneity suggested no evidence 
of difference between subgroups (p = 0.197); 
a lack of statistical power to detect differences 
may have contributed to this finding. The 
meta-estimate for lung cancer risk associ-
ated with PM10 for never-smokers was 1.11 
(95% CI: 0.94, 1.33). Estimates for current 
and former smokers were only available from 
one study, Raaschou-Nielsen et al. (2013), 
and were 1.27 (95% CI: 1.02, 1.58) and 0.98 
(95% CI: 0.67, 1.44), respectively.
Table 2 summarizes meta-estimates 
by subgroups of studies that account for 
confounding by smoking status, socio-
economic status (SES)/income, education, 
and occupation (which includes occupational 
exposure). The magnitude of the meta-
estimates of lung cancer risk associated with 
PM2.5 varied modestly but remained elevated 
Table 2. Estimates for the relationship between a 10-μg/m3 change in PM2.5 and PM10 exposure and lung 
cancer risk.
Exposure RR (95% CI) I2 (p-value)
Homogeneity 
testa Studies included (by ID)b
PM2.5
Full meta-estimate 1.09 (1.04, 1.14) 56.4% (0.007) All
Continent
North America 1.11 (1.05, 1.16) 6.5% (0.378) 2, 4, 6, 7, 8, 9, 10
Europe 1.03 (0.89, 1.20) 50.0% (0.112) 11, 12, 13, 15
Others 1.13 (0.94, 1.34) 91.0% (0.001) p = 0.656 16, 17
Exposure assessment method
Fixed site monitor 1.12 (1.04, 1.21) 77.1% (0.002) 2, 4, 8, 16, 17
Other 1.06 (1.00, 1.13) 16.2% (0.298) p = 0.268 5, 6, 7, 9, 10, 11, 12, 13, 15
Smoking status
Never 1.18 (1.00, 1.39) 0.0% (0.928) 3, 7, 8, 9, 10, 15
Former 1.44 (1.04, 2.01) 66.3% (0.031) 3, 8, 9, 15
Current 1.06 (0.97, 1.15) 0.0% (0.544) p = 0.197 3, 8, 9, 15
Confounder adjustment
Smoking status 1.10 (1.04, 1.17) 61.4% (0.004) 2, 4, 7, 8, 9, 10, 11, 12, 15, 
16, 17
SES/income 1.04 (0.96, 1.12) 24.2% (0.252) 5, 7, 10, 11, 13, 15
Education 1.07 (1.03, 1.11) 37.7% (0.117) 4, 8, 9, 10, 12, 13, 15, 16,
Occupation 1.08 (1.05, 1.11) 0.4% (0.420) 4, 6, 7, 9, 10, 13, 15
PM10
Full meta-estimate 1.08 (1.00, 1.17) 74.6% (> 0.001) All
Continent
North America 1.02 (0.96, 1.09) 57.7% (0.051) 1, 3, 6, 7, 10
Europe 1.27 (0.96, 1.68) 76.5% (0.014) 12, 14, 15
Others 1.16 (1.04, 1.29) — p = 0.074 18
Exposure assessment method
Fixed site monitor
Other 1.17 (0.93, 1.47) 87.3% (> 0.000) 1, 3, 14
Smoking status 1.07 (0.99, 1.15) 43.9% (0.113) p = 0.484 6, 7, 10, 12, 15, 18
Never
Former 1.11 (0.94, 1.33) 0.0% (0.407) 7, 10, 15
Current — — —
Confounder adjustment
Smoking status 1.08 (0.99, 1.17) 77.2% (> 0.001) 1, 3, 7, 10, 12, 14, 15, 18
SES/income 1.08 (0.97, 1.20) 65.5% (0.033) 7, 10, 15, 18
Education 1.11 (1.01, 1.21) 79.7% (> 0.001) 1, 3, 10, 12, 14, 15, 18
Occupation 1.02 (0.95, 1.10) 56.7% (0.055) 3, 6, 7, 10, 15
Estimates are the result of random-effects meta-analysis. RR, meta-relative risk.
ap-Value based on a chi-square distribution. bStudies included in the analysis according to ID numbers listed in Table 1.
Results from Naess et al. (2007) could not be converted to 10-μg/m3 units, and were, thus, excluded. The change in lung 
cancer mortality associated with a 1-quartile increase in PM2.5 and PM10 were identical, 1.26 (95% CI: 1.23, 1.28).Hamra et al.
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with various adjustments. The meta-estimates 
of lung cancer risk associated with PM10 
exposure behaved similarly, but there was 
some indication of greater sensitivity to the 
control of covariates, particularly occupation.
Histologic subtypes. Table 3 provides 
estimates of the relationship between PM2.5 
and PM10 and the two most frequent 
histological subtypes of lung cancer: adeno-
carcinoma and squamous cell carcinoma. The 
meta-estimates for adenocarcinoma associated 
with PM2.5 and PM10 were 1.40 (95% CI: 
1.07, 1.83) and 1.29 (95% CI: 1.02, 1.63), 
respectively. The meta-estimate of the relation-
ship between squamous cell carcinoma and 
PM2.5 is 1.11 (95% CI: 0.72, 1.72). The 
relation  ship between PM10 and squamous cell 
carcinoma was examined in only one study 
(Raaschou-Nielsen et al. 2013) in our review, 
which reported a meta-  relative risk of 0.84 
(95% CI: 0.50, 1.41) per 10 μg/m3.
Discussion
We conducted meta-analyses of the relation-
ship between exposure to ambient PM and 
lung cancer incidence and mortality. Meta-
estimates combine incidence and mortality 
studies due to the high fatality rate among 
incident lung cancers. These quantitative 
analyses complement the qualitative classifica-
tion of the evidence by the Monograph 109 
Working Group (IARC, in press). Most of the 
data were obtained from cohort studies, and 
our analytical results are similar across diverse 
study populations, potential confounders 
considered, as well as exposure assessment 
methods; this consistency supports the IARC 
Working Group’s conclusion that PM from 
outdoor air pollution is a Group 1 carcinogen 
and causes lung cancer. Air pollution is ubiq-
uitous, and all populations are exposed to it at 
some level, albeit with considerable variation 
between the most and the least polluted areas 
(Brauer et al. 2012). Thus, these results are 
important for policy makers and public health 
practitioners across the world.
In this analysis, we focused attention 
on PM2.5 and PM10, which are prominent 
components of the ambient air pollution 
mixture. Of course, PM10 includes the 
PM2.5 size fraction; however, these particle 
size groups are believed to differ in regard to 
human health effects. PM2.5 includes a higher 
proportion of mutagenic species (Buschini 
et al. 2001; Valavanidis et al. 2008), many 
of which are products of combustion (Brauer 
et al. 2001). Further, smaller particles pene-
trate more deeply into the lung and are more 
likely to be retained (Stuart 1976). On the 
other hand, the coarse fraction of the PM10-
size group consists mainly of minerals and 
biologic materials (Valavanidis et al. 2008). 
Thus, PM2.5 is generally believed to be most 
relevant to health effects, including cancer.
A number of potential confounders are 
often considered when examining the relation-
ship between PM and lung cancer risk, the 
most important overall being tobacco smoking. 
Meta-estimates for the relationship of PM2.5 
to lung cancer were consistent with the overall 
meta-estimate when restricting to studies that 
considered confounding by smoking status, 
SES/income, education, occupation, or sex. 
In addition, analyses by continent of study 
(Europe, North America, or other) yielded 
consistent, positive associations between PM2.5 
and lung cancer. For PM10, the data were 
less abundant and the findings of sensitivity 
analyses were less robust than for PM2.5.
We did not conduct statistical tests for 
assessment of publication bias, because these 
tests are specific to randomized controlled 
trials (Sterne et al. 2011) and rely on assump-
tions that are not applicable to meta-  analyses 
of observational research (Egger et al. 1998). 
We conducted trim and fill analyses, which 
require a strong assumption that a funnel plot 
should be symmetrical and that there is no 
between-study variance (Duval and Tweedie 
2000; Higgins et al. 2008). Conclusions 
regarding the relationship between PM2.5 and 
lung cancer risk were robust. Trim and fill 
analyses for PM10 and lung cancer risk led to a 
null-centered estimate; however, this required 
trimming and filling four out of 10 studies. In 
short, a large number of hypothetical studies 
would be required to construct a symmetrical 
funnel plot and change the results of our 
meta-analyses. In addition, results for lung 
cancer risk from PM2.5 and PM10 were robust 
to influence analyses, where the meta-estimate 
was recalculated with the systematic exclusion 
of each study.
Exposure assessment techniques differed 
across studies. Some studies used fixed site 
monitors, and others employed more 
complex modeling approaches; regardless of 
the method used, all individuals in a study 
are assigned an estimate of individual-level 
exposure. Modeling techniques, such as land 
use regression and air dispersion, attempt to 
provide residential estimates of exposure to 
PM, whereas fixed site monitor techniques 
indicate group-level exposures without further 
modeling. In fact, none of the exposure 
assessment methods used provides a true, 
individual-level measure of exposure to PM. 
Meta-estimates of lung cancer risk associated 
with both PM2.5 and PM10 from studies using 
fixed site monitors were slightly higher than 
those obtained from studies using advanced 
exposure modeling methods. However, homo-
geneity tests suggest no difference in estimates 
between exposure assessment techniques.
In addition to adjusting for smoking status, 
some studies provided analyses for PM2.5 by 
smoking subgroups allowing assessment–
differential effects of PM by smoking status 
(current, former, and never-smokers). Data 
were limited for examin  ing the relationship 
between PM10 and lung cancer risk: Only 
three studies provided any subgroup-specific 
information, which pertained only to never-
smokers. Six studies provided information 
on the relationship between PM2.5 and lung 
cancer by current, former, or never-smoking 
status, and one presented results specific to 
never-smokers. Meta-estimates from these 
studies suggest that never- and former smokers 
may have an elevated risk of lung-cancer 
associated with PM2.5 compared to current 
smokers; however, even current smokers exhib-
ited a modest, but imprecise, elevated risk 
of lung cancer due to PM2.5. Further, these 
results are limited by lack of detailed informa-
tion on patterns of former smoking. We are 
not able to disentangle effects of air pollution 
on lung cancer risk between former heavy 
versus former light smokers, which might 
be expected to differ. Homogeneity tests did 
not provide support for different effects by 
smoking subgroups.
In a recent study of a large cohort of 
U.S. non-metal miners, Silverman et al. 
(2012) reported a dose–response curve that 
was steeper at lower exposures to respirable 
elemental carbon (a marker for diesel exhaust) 
and leveled off at higher exposures. In that 
study, the authors observed reduced diesel 
exhaust–associated lung cancer risk among 
heavy smokers. This pattern is similar to 
our observation of a smaller lung cancer risk 
associated with PM for current smokers. 
Silverman et al. (2012) proposed a number of 
biological mechanisms to explain this effect, 
such as polycyclic aromatic hydrocarbons—
present in tobacco smoke, diesel exhaust, and 
PM2.5—competing for metabolic activation, 
Table 3. Estimates for the relationship between a 10-μg/m3 change in PM2.5 and PM10 and histological 
cancer subtypes.
Exposure and outcome RR (95% CI) n Studies included (by ID)a
PM2.5
Adenocarcinoma 1.40 (1.07, 1.83) 2,339 9, 10, 15
Squamous cell carcinoma 1.11 (0.72, 1.72) 1,523 9, 15
PM10
Adenocarcinoma 1.29 (1.02, 1.63) 965 10, 15
Squamous cell carcinoma — — —
RR, meta-relative risk. Estimates are the result of random-effects meta-analysis. 
aStudies included in the analysis according to ID numbers listed in Table 1.Air pollution and lung cancer risk
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and decreased lung deposition of diesel 
exhaust among smokers. However, the exact 
mechanism leading to this reduced risk among 
smokers is still unclear. Thus, more careful 
consideration of potential interaction between 
PM and smoking for lung cancer and other 
diseases seems warranted; large, robust data sets 
will be needed for this work.
The original risk estimates included 
in our analyses assume a log-linear relation 
between PM exposure and lung cancer rates. 
Thus, the data available for this meta-analysis 
do not provide the opportunity to further 
evaluate this assumption. However, alterna-
tives to a linear exposure–response model 
have been considered in analyses of data from 
the ACS-CPS II (Pope et al. 2002; Turner 
et al. 2011), Harvard Six Cities (Lepeule et al. 
2012), Canadian National Enhanced Cancer 
Surveillance System (Hystad et al. 2013), 
Rome Longitudinal (Cesaroni et al. 2013), 
NHS (Puett et al. 2014), and ESCAPE 
(Raaschou-Nielsen et al. 2013) studies, which 
included categorical modeling and application 
of smoothing functions. All of these analyses 
concluded that there is no evidence of marked 
deviation from linearity. Pope et al. (2011) 
also reported a near linear relation of lung 
cancer risk with estimated daily PM2.5 dose 
in an analysis that integrated information on 
lung cancer risk associated findings of risk 
from diverse combustion sources.
Conclusion
The results of these analyses, and the decision 
of the IARC Working Group to classify 
outdoor air pollution as a Group 1 carcin-
ogen, further justify efforts to reduce expo-
sures to air pollutants, which can arise from 
many sources. The Global Burden of Disease 
collaboration estimated that approximately 
3.22 million deaths were caused by exposure 
to air pollution in 2010, an increase from 
2.91 million deaths attributed to air pollu-
tion in 1990 (Lim et al. 2012). Cancers of the 
trachea, bronchus, or lung represent approxi-
mately 7% of total mortality attributable 
to PM2.5 in 2010. The results of the meta-
analysis provided here could be useful for 
better quantifying the burden of lung cancer 
associated with air pollution. The Group I 
classification raises questions regarding 
individual components in the air pollution 
mixture regarding, for example, the carcino-
genic potential of each component as well as 
through what pathways they may contribute 
to cancer risk.
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Erratum
Erratum: “Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis”
In the original online version of “Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis” by 
Hamra et al. [Environ Health Perspect 122:906–911 (2014); http://dx.doi.org/10.1289/ehp.1408092], there were several errors. In 
Table 1, the number of events for Krewski et al. (2009; United States) and for Beelen et al. (2008; Netherlands) should have been “9,788 
(mortality)” and “1,940 (incidence),” respectively. In Figure 1A, all of the weights were incorrect, as was the RR (95% CI) for the North 
America subtotal [it should have been “1.11 (1.05, 1.16)” instead of “1.10 (1.06, 1.14)”]. Finally, in Table 2, the study ID numbers for the 
PM2.5 subanalyses for North America should not have included “5”; the correct study numbers are 2, 4, 6, 7, 8, 9, and 10. All of these errors 
have been corrected.
The authors regret the errors.
All EHP content is accessible to individuals with disabilities. A fully accessible (Section 508–compliant) 
HTML version of this article is available at http://dx.doi.org/10.1289/ehp.122-A236.  